| abstract |
The compounds or a pharmaceutically acceptable salt thereof have the formula wherein the substituents have the meanings given in the description and R5 and R6 taken together form the structures of the partial formulas. They are useful as inhibitors of PDE4 in the treatment of diseases which are regulated by activation and degranulation of eosinophils, especially asthma, chronic bronchitis and chronic obstructive pulmonary diseases. |